title: Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.
abstract: The principal aim of this study was to develop, validate, and demonstrate a physiologically based pharmacokinetic (PBPK) model to predict and characterize the absorption, distribution, metabolism, and excretion of acetaminophen (APAP) in humans. A PBPK model was created that included pharmacologically and toxicologically relevant tissue compartments and incorporated mechanistic descriptions of the absorption and metabolism of APAP, such as gastric emptying time, cofactor kinetics, and transporter-mediated movement of conjugated metabolites in the liver. Through the use of a hierarchical Bayesian framework, unknown model parameters were estimated using a large training set of data from human pharmacokinetic studies, resulting in parameter distributions that account for data uncertainty and inter-study variability. Predictions from the model showed good agreement to a diverse test set of data across several measures, including plasma concentrations over time, renal clearance, APAP absorption, and pharmacokinetic and exposure metrics. The utility of the model was then demonstrated through predictions of cofactor depletion, dose response of several pharmacokinetic endpoints, and the relationship between APAP biomarker levels in the plasma and those in the liver. The model addressed several limitations in previous PBPK models for APAP, and it is anticipated that it will be useful in predicting the pharmacokinetics of APAP in a number of contexts, such as extrapolating across doses, estimating internal concentrations, quantifying population variability, assessing possible impacts of drug coadministration, and, when coupled with a suitable pharmacodynamic model, predicting toxicity.
authors: Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, 80523-1370, USA.
authors: Todd J
authors: TJ
authors: Zurlinden
authors: Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, 80523-1370, USA. brad.reisfeld@colostate.edu.|School of Biomedical Engineering, Colorado State University, Fort Collins, CO, 80523-1370, USA. brad.reisfeld@colostate.edu.
authors: Brad
authors: B
authors: Reisfeld
mesh_terms: D000082:Acetaminophen / Q000378:metabolism* / Q000493:pharmacokinetics*; D001499:Bayes Theorem; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism; D008954:Models, Biological; D014018:Tissue Distribution
chemical_list: D015415:Biomarkers; D000082:Acetaminophen
keywords: APAP; Acetaminophen; Bayesian population; PBPK; Physiologically based pharmacokinetic modeling
references: Clin Pharmacokinet. 2006;45(10 ):1013-34
references: 16984214
references: Br J Clin Pharmacol. 2013 Feb;75(2):450-62
references: 22725836
references: J Pharm Pharmacol. 1963 Jul;15:440-4
references: 13951545
references: Biol Pharm Bull. 2007 Jan;30(1):157-61
references: 17202677
references: Eur J Clin Pharmacol. 1993;45(6):551-3
references: 8157041
references: Chem Res Toxicol. 2006 May;19(5):701-9
references: 16696573
references: J Clin Pharm Ther. 2005 Apr;30(2):179-84
references: 15811172
references: Br J Clin Pharmacol. 1986 Sep;22(3):363-6
references: 3768251
references: Clin Pharmacol Ther. 1978 Oct;24(4):420-31
references: 688732
references: Clin Chem. 2011 Jan;57(1):9-11
references: 21189276
references: J Pharm Sci. 1991 Sep;80(9):855-60
references: 1800709
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Sep 1;904:42-50
references: 22867840
references: J Pharm Pharmacol. 2002 Jun;54(6):869-73
references: 12079004
references: Eur J Clin Pharmacol. 1989;36(3):291-7
references: 2744070
references: Br J Clin Pharmacol. 1986 Dec;22(6):649-57
references: 3567011
references: Biopharm Drug Dispos. 1994 Jan;15(1):1-31
references: 8161713
references: J Pharm Sci. 1984 Aug;73(8):1038-41
references: 6491906
references: Xenobiotica. 2009 Jan;39(1):11-21
references: 19219744
references: Drug Metab Dispos. 1985 Jan-Feb;13(1):35-41
references: 2858374
references: Mol Pharmacol. 2006 Jun;69(6):2084-92
references: 16517757
references: BMC Pharmacol Toxicol. 2013 Jun 24;14:34
references: 23800230
references: Nucleic Acids Res. 2013 Jan;41(Database issue):D801-7
references: 23161693
references: Drug Metab Dispos. 1989 May-Jun;17(3):341-4
references: 2568918
references: Bioinformatics. 2009 Jun 1;25(11):1453-4
references: 19304877
references: Eur J Clin Pharmacol. 1977 Apr 20;11(4):283-6
references: 862649
references: Xenobiotica. 2009 May;39(5):374-81
references: 19280384
references: J Pharm Biomed Anal. 1994 Dec;12(12):1563-72
references: 7696381
references: J Pharm Sci. 2006 Jun;95(6):1238-57
references: 16639716
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 15;893-894:162-7
references: 22445307
references: Clin Pharmacol Ther. 1996 Dec;60(6):651-60
references: 8988067
references: Pharmacol Rev. 1997 Dec;49(4):403-49
references: 9443165
references: Drug Metab Dispos. 2003 May;31(5):580-8
references: 12695346
references: Eur J Clin Pharmacol. 1993;45(2):141-5
references: 8223835
references: J Toxicol Clin Toxicol. 2002;40(1):3-20
references: 11990202
references: J Clin Pharmacol. 1994 Jun;34(6):692-8
references: 8083402
references: Br J Clin Pharmacol. 1980 Oct;10 Suppl 2:291S-298S
references: 7002186
references: Emerg Med Australas. 2010 Dec;22(6):548-55
references: 21143403
references: J Pharmacol Exp Ther. 1984 Feb;228(2):407-13
references: 6694118
references: Integr Biol (Camb). 2013 Jun;5(6):877-88
references: 23632663
references: Br J Clin Pharmacol. 1984 Oct;18(4):481-5
references: 6487489
references: Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84
references: 9249929
references: Environ Health Perspect. 2008 Aug;116(8):1040-6
references: 18709138
references: Eur J Clin Pharmacol. 1997;52(4):285-8
references: 9248766
references: Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):233-9
references: 8980921
references: J Pharmacobiodyn. 1990 Jun;13(6):327-35
references: 2231264
references: J Pharm Biomed Anal. 2004 Feb 18;34(3):585-93
references: 15127815
references: Toxicol Appl Pharmacol. 2009 Nov 15;241(1):36-60
references: 19660485
references: Toxicol Lett. 2013 Jun 20;220(1):26-34
references: 23566899
references: Methods Mol Biol. 2012;929:289-312
references: 23007434
references: J Chromatogr. 1981 Nov 13;226(1):224-30
references: 7320146
references: Methods Mol Biol. 2012;929:439-99
references: 23007440
references: Int J Pharm. 2001 Jul 17;222(2):305-8
references: 11427360
references: Br J Clin Pharmacol. 2011 Feb;71(2):199-206
references: 21219400
references: Eur J Pharm Sci. 2006 Jan;27(1):72-9
references: 16169713
references: Clin Pharmacokinet. 1982 Mar-Apr;7(2):93-107
references: 7039926
references: Theor Biol Med Model. 2012 Dec 19;9:55
references: 23249634